SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-17-008051
Filing Date
2017-09-01
Accepted
2017-09-01 07:30:36
Documents
3
Effectiveness Date
2017-09-01

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL MATERIALS opxa_defa14a.htm DEFA14A 25039
2 IMAGE opxa_defa14a000.jpg GRAPHIC 3947
3 IMAGE opxa_defa14a001.jpg GRAPHIC 2590
  Complete submission text file 0001654954-17-008051.txt   35646
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33004 | Film No.: 171064463
SIC: 2834 Pharmaceutical Preparations